29 GHP Q2 2024 cross the medical sector, in vitro diagnostics can mean the difference between decades of suffering and providing those afflicted with various diseases, conditions, and infections a chance to live their lives to the fullest once again. Capable of picking up on a multitude of ailments, it’s an irrefutably incredible form of testing that has produced results time and time again. So, when Fortress Diagnostics came onto the scene with a promise to elevate the IVD market to the next level, it’s not at all surprising that the industry welcomed it with open arms. Now, it’s recognised as a champion of its craft – an entity capable of supplying a broad range of clinical diagnostic tests to medical professionals and centres around the world. Leveraging its global network, Fortress Diagnostics has already had an astounding impact on the world of medical testing. Not only has it delivered solutions to hospitals, medical centres, clinics, blood banks, and institutions alike, but it’s done so while remaining fluid, innovative, and attentive. Keeping oneself aligned with the growing and fluctuating demands of the diagnostic sector is no easy feat, and yet Fortress Diagnostics makes it seem like an effortless task – a trait that stands as a testament to just how adept it is in its field. Already, Fortress Diagnostics has delivered solutions to over 100 international markets, all while upholding an exceptional level of quality that doesn’t go unnoticed. In the company’s own words – “Fortress Diagnostics is fully committed to the advancement of the diagnostic industry. We reinvest a staggering 30% of turnover into Research and Development each year, and employ a highly skilled team of research scientists to innovate new - and optimise existing - products to ensure that the diagnostic tests we produce are at the forefront of technology.” Where most may be satisfied with sitting in a successful position, Fortress Diagnostics is committed to making use of every tool at its disposal in order to guarantee an even brighter future for the diagnostic industry. Regardless of how difficult the task may be, Fortress Diagnostics refuses to shy away from taking those brave new steps into the future of the medical sphere. For the past 24 years, Fortress Diagnostics has been doing more than simply meeting its distributors’ and end users’ expectations – it has put in the hard work and dedication to ensure that these expectations are beyond exceeded. Be it through prioritising quality, providing products at a competitive price, or granting clients access to a knowledgeable team of customer service experts, Fortress Diagnostics has established itself as a reliable entity for any seeking comprehensive IVD solutions. As such, it’s Proudly standing as a multi award-winning global provider of in vitro diagnostics, Fortress Diagnostics is an uncontested master of developing, manufacturing, and supporting a rich portfolio of clinical diagnostic tests. Operating out of its accredited, UK-based facility, the collective goes above and beyond to offer much needed solutions to various areas of the diagnostic industry. From immunology to haematology and serological laboratories, Fortress Diagnostics is a bastion of industry-wide innovation. Below, we explore how its unique approach to the market has earned it Global Health & Pharma’s title of IVD Product Manufacturer of the Year 2024 – UK. Fortifying the World of Diagnostics accumulated a fantastic reputation that will no doubt continue to propel it forward in its venture toward a better tomorrow. Global Health & Pharma exists as a means to identify those within the medical sector who are actively making a positive contribution toward their specialised markets. Fortress Diagnostics is a prime example of just this – as an award-winning collective in constant pursuit of new, innovative solutions, it’s distinguished itself as a remarkable collective whose reputation speaks for itself. It’s for this reason that we’re pleased to present Fortress Diagnostics with the title of IVD Product Manufacturer of the Year 2024 – UK, and we look forward to seeing how it leverages emerging technologies in the near future. Contact: James Cartwright Company: Fortress Diagnostics Limited Web Address: https://www.fortressdiagnostics.com/ A Mar24417
RkJQdWJsaXNoZXIy MTUyMDQwMA==